Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2025-12-25 @ 5:07 AM
NCT ID:
NCT02840227
Eligibility Criteria:
Inclusion Criteria:
1. Tumor thought to be primary non-small cell lung cancer (stage 1-3) as determined according to the IASLC Lung Cancer Staging Project\[ref\];
2. Scheduled for potentially curative tumor resection;
3. Written informed consent, including willingness to be randomized to epidural anesthesia/analgesia plus general anesthesia or to general anesthesia and postoperative opioid analgesia;
4. ASA physical status 1-3.
Exclusion Criteria:
1. Any contraindication to epidural anesthesia, (including coagulopathy, abnormal anatomy).
2. Any contraindication to midazolam, propofol, sevoflurane, fentanyl, morphine, or hydromorphone.
3. Age \<18 or \>85 years old.
4. Other cancer not believed by the attending surgeon to be in long-term remission.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02840227
Study Brief:
Protocol Section:
NCT02840227